UBS Assumes Twist Bioscience (TWST) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts TWST Hot Sheet
Price: $139.92 +3.28%
Rating Summary:
12 Buy, 3 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
12 Buy, 3 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
UBS analyst Douglas Schenkel assumes coverage on Twist Bioscience (NASDAQ: TWST) with a Neutral rating and a price target of $144.00.
For an analyst ratings summary and ratings history on Twist Bioscience click here. For more ratings news on Twist Bioscience click here.
Shares of Twist Bioscience closed at $128.06 yesterday.
You May Also Be Interested In
- Northland Starts Unusual Machines (UMAC) at Outperform
- Needham Assumes Benchmark (BHE) at Buy
- Citi Starts Kewpie Corp (2809:JP) at Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
